Digital Medicine Platform for Treatment of Cognitive Disorder
[ad_1] Akili, a pioneer in therapeutic prescription digital medicine has closed successfully it’s $55 million financing Series C trial of medicine. This funding follows a successful trial, including study, developing and testing a novel digital medicine named AKL- T01. This flagship product of Akili aimed to treat a type of cognitive disorder- attention deficit/hyperactivity disorder […]
Digital Medicine Platform for Treatment of Cognitive Disorder Read More »